- Home
- TXMD vs BHV Comparison
TXMD vs BHV Comparison
Compare TXMD & BHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- BHV
- Stock Information
- Founded
- TXMD 2008
- BHV 2002
- Country
- TXMD United States
- BHV United States
- Employees
- TXMD N/A
- BHV N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- BHV Finance/Investors Services
- Sector
- TXMD Health Care
- BHV Finance
- Exchange
- TXMD Nasdaq
- BHV Nasdaq
- Market Cap
- TXMD 17.1M
- BHV 16.2M
- IPO Year
- TXMD N/A
- BHV N/A
- Fundamental
- Price
- TXMD $1.09
- BHV $10.39
- Analyst Decision
- TXMD
- BHV
- Analyst Count
- TXMD 0
- BHV 0
- Target Price
- TXMD N/A
- BHV N/A
- AVG Volume (30 Days)
- TXMD 66.5K
- BHV 3.5K
- Earning Date
- TXMD 08-11-2025
- BHV 01-01-0001
- Dividend Yield
- TXMD N/A
- BHV 3.35%
- EPS Growth
- TXMD N/A
- BHV N/A
- EPS
- TXMD N/A
- BHV N/A
- Revenue
- TXMD $1,841,000.00
- BHV N/A
- Revenue This Year
- TXMD $427.09
- BHV N/A
- Revenue Next Year
- TXMD N/A
- BHV N/A
- P/E Ratio
- TXMD N/A
- BHV N/A
- Revenue Growth
- TXMD 53.55
- BHV N/A
- 52 Week Low
- TXMD $0.70
- BHV $8.85
- 52 Week High
- TXMD $2.44
- BHV $12.08
- Technical
- Relative Strength Index (RSI)
- TXMD 38.09
- BHV 54.98
- Support Level
- TXMD $1.07
- BHV $10.20
- Resistance Level
- TXMD $1.22
- BHV $10.29
- Average True Range (ATR)
- TXMD 0.13
- BHV 0.09
- MACD
- TXMD -0.02
- BHV 0.03
- Stochastic Oscillator
- TXMD 19.15
- BHV 64.10
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About BHV BlackRock Virginia Municipal Bond Trust
Blackrock Virginia Municipal Bond Trust is a perpetual closed-end municipal bond fund. Its objective is to provide current income exempt from regular Federal income taxes and Virginia personal income taxes.